US Patent Issued to Eikonizo Therapeutics on June 16 for "HDAC6 inhibitors and uses thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,655,106, issued on June 16, was assigned to Eikonizo Therapeutics Inc. (Cambridge, Mass.).

"HDAC6 inhibitors and uses thereof" was invented by Florence Fevrier Wagner (Ashland, Mass.) and Dean Hickman (Belmont, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compounds that selectively inhibit HDAC6, a protein whose activity is associated with a variety of diseases (e.g., cancer, neurological disorders). Also provided are pharmaceutical compositions and kits comprising the compounds, and methods of treating HDAC6-related diseases and disorders (e.g., Alzheimer's disease, cancer) with the compounds in a subject, by administering t...